Righi, I.; Maiorca, S.; Diotti, C.; Bonitta, G.; Mendogni, P.; Tosi, D.; Nosotti, M.; Rosso, L.
Oncological Outcomes of Segmentectomy versus Lobectomy in Clinical Stage I Non-Small Cell Lung Cancer up to Two Centimeters: Systematic Review and Meta-Analysis. Life 2023, 13, 947.
https://doi.org/10.3390/life13040947
AMA Style
Righi I, Maiorca S, Diotti C, Bonitta G, Mendogni P, Tosi D, Nosotti M, Rosso L.
Oncological Outcomes of Segmentectomy versus Lobectomy in Clinical Stage I Non-Small Cell Lung Cancer up to Two Centimeters: Systematic Review and Meta-Analysis. Life. 2023; 13(4):947.
https://doi.org/10.3390/life13040947
Chicago/Turabian Style
Righi, Ilaria, Sebastiano Maiorca, Cristina Diotti, Gianluca Bonitta, Paolo Mendogni, Davide Tosi, Mario Nosotti, and Lorenzo Rosso.
2023. "Oncological Outcomes of Segmentectomy versus Lobectomy in Clinical Stage I Non-Small Cell Lung Cancer up to Two Centimeters: Systematic Review and Meta-Analysis" Life 13, no. 4: 947.
https://doi.org/10.3390/life13040947
APA Style
Righi, I., Maiorca, S., Diotti, C., Bonitta, G., Mendogni, P., Tosi, D., Nosotti, M., & Rosso, L.
(2023). Oncological Outcomes of Segmentectomy versus Lobectomy in Clinical Stage I Non-Small Cell Lung Cancer up to Two Centimeters: Systematic Review and Meta-Analysis. Life, 13(4), 947.
https://doi.org/10.3390/life13040947